Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Few Cancer Screening Trials Quantify Harm from Screening

NEW YORK (Reuters Health) – A review of the literature has shown that the most important harms from cancer screening are often not quantified in screening trials. “Healthcare decision makers, healthcare practitioners, and, ultimately, patients...
Sales of Ariad Pharmaceutical‘s Iclusig for treatment of chronic myeloid leukemia have come to a halt after the FDA issued a statement reporting on adverse vascular events associated with the drug, The New York Times reports. The drug was approved...

Reuters Health • The Doctor's Channel Daily Newscast

Adjuvant Chemotherapy Helpful for Stage III Mucinous Colorectal Cancer

NEW YORK (Reuters Health) – A Dutch population-based study has shown that, while mucinous colorectal cancer is thought to carry a poor prognosis, it actually responds as well to adjuvant chemotherapy as nonmucinous CRC. “Therefore, current adjuvant...